Research is aimed at funding a deeper understanding of the (unrecognised yet treatable) neuro-endocrine consequences of brain injury after tumours and cancer related therapies.

Neuroendocrine ‘late effects’ start with the tumour and are aggravated by treatment and failed rehabilitation. Understanding the causes of each –and which treatments are most implicated –will help oncologists tailor therapies in the future. This requires very long term (more than 7 to 10 years) outcome data collection from diagnosis.

We advocate

By contributing internationally across interdisciplinary boundaries to reports on clinical need, (best practice guidance) and initiatives to improve health related survival outcomes.

We research

By seed-funding an academic PhD programme to study the neuro-endocrine causes of hypothalamic dysfunction and its secondary life-limiting consequences after diencephalic brain tumours and cancer related therapies.

We invest

By establishing dedicated multi-disciplinary team to undertake clinical research (into long term outcomes )from a dedicated electronic patient database and provide longevity of service to support survivors.

Our projects – how your money is invested

We advocate

  • Audit clinical research guidance
  • Attendance at conferencesn

We research

  • Part-fund PhDs research programs
  • Resources for medical professionals

We invest

Find out more about our long term proposal for multi-disciplinary sensory services